Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2009 4
2010 1
2011 2
2012 3
2013 3
2014 3
2015 2
2016 3
2017 6
2018 3
2019 4
2020 3
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E, Mikesch JH, Hafner S, Simmet T, Wozniak A, Schöffski P, Larsson O, Wardelmann E, Trautmann M, Hartmann W. Isfort I, et al. Among authors: altvater b. Clin Cancer Res. 2019 Jun 15;25(12):3718-3731. doi: 10.1158/1078-0432.CCR-17-3553. Epub 2019 Feb 27. Clin Cancer Res. 2019. PMID: 30814111 Free article.
Requirement for YAP1 signaling in myxoid liposarcoma.
Trautmann M, Cheng YY, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S. Trautmann M, et al. Among authors: altvater b. EMBO Mol Med. 2019 May;11(5):e9889. doi: 10.15252/emmm.201809889. EMBO Mol Med. 2019. PMID: 30898787 Free PMC article.
VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma.
Englisch A, Altvater B, Kailayangiri S, Hartmann W, Rossig C. Englisch A, et al. Among authors: altvater b. Pediatr Blood Cancer. 2020 Oct;67(10):e28313. doi: 10.1002/pbc.28313. Epub 2020 Jul 30. Pediatr Blood Cancer. 2020. PMID: 32729251
Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers.
Rossig C, Kailayangiri S, Jamitzky S, Altvater B. Rossig C, et al. Among authors: altvater b. Front Oncol. 2018 Nov 12;8:513. doi: 10.3389/fonc.2018.00513. eCollection 2018. Front Oncol. 2018. PMID: 30483473 Free PMC article. Review.
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma.
Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S, Simmet T, Becker J, Åman P, Wardelmann E, Huss S, Hartmann W. Trautmann M, et al. Among authors: altvater b. Mol Cancer Ther. 2019 Apr;18(4):834-844. doi: 10.1158/1535-7163.MCT-18-0763. Epub 2019 Feb 20. Mol Cancer Ther. 2019. PMID: 30787173 Free article.
Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines.
Zimmermann K, Kuehle J, Dragon AC, Galla M, Kloth C, Rudek LS, Sandalcioglu IE, Neyazi B, Moritz T, Meyer J, Rossig C, Altvater B, Eiz-Vesper B, Morgan MA, Abken H, Schambach A. Zimmermann K, et al. Among authors: altvater b. Cancers (Basel). 2020 Feb 6;12(2):375. doi: 10.3390/cancers12020375. Cancers (Basel). 2020. PMID: 32041222 Free PMC article.
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells.
Kailayangiri S, Altvater B, Lesch S, Balbach S, Göttlich C, Kühnemundt J, Mikesch JH, Schelhaas S, Jamitzky S, Meltzer J, Farwick N, Greune L, Fluegge M, Kerl K, Lode HN, Siebert N, Müller I, Walles H, Hartmann W, Rossig C. Kailayangiri S, et al. Among authors: altvater b. Mol Ther. 2019 May 8;27(5):933-946. doi: 10.1016/j.ymthe.2019.02.014. Epub 2019 Feb 23. Mol Ther. 2019. PMID: 30879952 Free PMC article.
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M, Menzel J, Bertling C, Cyra M, Isfort I, Steinestel K, Elges S, Grünewald I, Altvater B, Rossig C, Fröhling S, Hafner S, Simmet T, Åman P, Wardelmann E, Huss S, Hartmann W. Trautmann M, et al. Among authors: altvater b. Clin Cancer Res. 2017 Oct 15;23(20):6227-6238. doi: 10.1158/1078-0432.CCR-17-0130. Epub 2017 Jun 21. Clin Cancer Res. 2017. PMID: 28637688 Free article.
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G.
Spurny C, Kailayangiri S, Altvater B, Jamitzky S, Hartmann W, Wardelmann E, Ranft A, Dirksen U, Amler S, Hardes J, Fluegge M, Meltzer J, Farwick N, Greune L, Rossig C. Spurny C, et al. Among authors: altvater b. Oncotarget. 2017 Dec 22;9(5):6536-6549. doi: 10.18632/oncotarget.23815. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464090 Free PMC article.
37 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page